Pages

Friday, December 23, 2011

SCOLR Pharma, Inc. Announces Initial Shipments of its Nutritional Products

BOTHELL, Wash., Dec. 23, 2011 /PRNewswire/ -- SCOLR Pharma, Inc. (OTCQB: SCLR) today announced that it has  received and shipped initial retail orders for its extended-release nutritional products based on the Company's proprietary CDT® oral drug delivery platform. The shipments represent SCOLR's first significant direct retail sales of its nutritional products. Stephen J. Turner, SCOLR Pharma's President and CEO, said, "Shipment of these initial orders marks an important milestone f...continued
 

No comments:

Post a Comment